首页> 外文会议>Society for Biomaterials annual meeting and exposition >Development of dual-action topical therapeutics for cytomegalovirus-induced hearing loss
【24h】

Development of dual-action topical therapeutics for cytomegalovirus-induced hearing loss

机译:巨细胞病毒引起的听力丧失双作用局部疗法的开发

获取原文

摘要

Our data so far highlight the feasibility of chemically conjugating HA with antioxidants while preserving the protective function of the selected drugs. We anticipate that the results of our ongoing experiments will support our hypothesis that HA conjugation with antioxidants can protect inner ear specific cells by synergistically reducing inflammation, oxidative stress and by enhancing the drug's permeability across the RMW. The generated data will be used to inform future in vivo studies in representative preclinical models.
机译:迄今为止,我们的数据突出了在保持所选药物的保护功能的同时将HA与抗氧化剂化学偶联的可行性。我们预期正在进行的实验结果将支持我们的假设,即HA与抗氧化剂结合可通过协同减少炎症,氧化应激并增强药物在RMW的通透性来保护内耳特异性细胞。生成的数据将用于在代表性的临床前模型中为将来的体内研究提供信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号